USPTO serial 79363341
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Diagnostic preparations for medical purposes relating to obstetrics or breast cancer; chemical reagents for medical purposes relating to obstetrics or breast cancer; diagnostic biomarker reagents for medical purposes; reagents for use in medical genetic testing; pharmaceutical drugs for the treatment of breast cancer; pharmaceutical preparations for the prevention and treatment of breast cancer; pharmaceutical products for the prevention and treatment of breast cancer; biological preparations for the treatment of breast cancer | ACTIVE | — |
| 010 | Testing apparatus for medical purposes relating to obstetrics and breast cancer for detecting cancer; genetic testing apparatus for medical purposes; diagnostic apparatus for medical purposes relating to obstetrics and breast cancer; apparatus for use in medical analysis relating to obstetrics or breast cancer for detecting cancer; medical apparatus and instruments relating to obstetrics and breast cancer; apparatus for DNA and RNA testing for medical purposes, namely, X-ray diagnostic apparatus | ACTIVE | — |
| 042 | Scientific research in the fields of obstetrics and breast cancer; scientific research on breast cancer for medical purposes; scientific research in the nature of conducting clinical trials for others in the fields of obstetrics and breast cancer; medical research in the fields of obstetrics and breast cancer; structural and functional analysis of genomes; research and development of pharmaceuticals of breast cancer; medical research in oncology, namely, breast cancer; genetic testing for scientific research; technological research in the fields of obstetrics and breast cancer | ACTIVE | — |
| 044 | Genetic testing for medical use; genetic testing for medical purposes; telemedicine services on medical testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening relating to obstetrics and breast cancer; rental of medical equipment, namely, equipment relating to obstetrics and breast cancer; medical therapy services in the fields of obstetrics and breast cancer; medical analysis services for the diagnosis of breast cancer; provide breast cancer screening services | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 28, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 12, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 12, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 7, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 16, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 16, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 4, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 4, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 4, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 19, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 19, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 28, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 28, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 15, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 12, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 12, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 12, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 31, 2023 | ATRV | ATTORNEY REVIEW COMPLETED | — |
| Oct 30, 2023 | CREV | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED | — |
| Sep 16, 2023 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Aug 1, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 13, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 13, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 6, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 5, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 27, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 25, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 4, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 28, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 27, 2023 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Feb 23, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |